A tandem repeat of MUC1 core protein induces a weak in vitro immune response in human B cells |
| |
Authors: | Eva Andersson Paula Henderikx Elias Krambovitis Hennie R. Hoogenboom Carl A. K. Borrebaeck |
| |
Affiliation: | (1) Department of Immunotechnology, Lund University, P.O. Box 7031, S-220 07 Lund, Sweden e-mail: carl.borrebaeck@immun.lth.se Fax: +46-46-222 4200, SE;(2) CESAME, Department of Pathology, University Hospital and Maastricht University, Maastricht, The Netherlands, NL;(3) Laboratory of Applied Biochemistry and Immunology, Institute of Molecular Biology and Biotechnology, Heraklion, Greece, GR |
| |
Abstract: | We have recently described an efficient method to study the human humoral immune response in vitro and to generate isotype-switched, antigen-specific human B cells, which has allowed us to produce high-affinity IgG antibodies against different peptides. In an attempt to study the in vitro immune response against self-antigens, such as tumour-associated antigens, this protocol was used to immunise resting human peripheral blood B cells with a peptide epitope from the human-adenocarcinoma-associated antigen, MUC1. After the two-step in vitro immunisation, the secondary immunised cultures were tested for MUC-1-specific antibodies by enzyme-linked immunosorbent assay (ELISA). Phage molecular libraries were subsequently constructed, using the variable parts of Ig genes derived from cells taken from ELISA-positive wells. The libraries were selected on the MUC1 core peptide. Antigen-specific Fab fragments, specific for the self antigen MUC1, were found in the library of secondary immunised IgG+ B cells and these antibodies were evaluated by BIAcore analysis. The specific Fab fragments exhibited an unusually rapid dissociation rate constant and the overall response frequency was lower, as compared to other antibodies generated by this protocol, which might be explained by the repetitive nature of the core peptide used for immunisation. Received: 30 June 1998 / Accepted: 24 September 1998 |
| |
Keywords: | In vitro immunisation MUC1 Human antibodies Phage display Carcinoma |
本文献已被 PubMed SpringerLink 等数据库收录! |
|